Skip to main content
Equibles

PYPD · PolyPid Ltd. · Earnings Call Transcripts & Audio

Track PYPD — free

Use PYPD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PYPD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.15 -0.01 (-0.19%) At close · Sep 11
Rebalance outlook locked
Market Cap
$104.61M
Shares
20.31M

PolyPid Ltd. Earnings Call Transcripts

Quarterly earnings calls for PolyPid Ltd. (PYPD), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q2
2026-08-12
PolyPid Ltd. (PYPD) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-19
PolyPid Ltd. (PYPD) Q1 2026 Earnings Call Transcript
Confident tone D-PLEX100 NDA Submission and Regulatory Progress FDA Manufacturing Inspection Readiness Cash Runway and Financial Position
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-11
PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript
Confident tone Kynatrix technology platform introduction D-PLEX100 regulatory progress and NDA submission Commercialization readiness and IDN/hospital uptake
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
PolyPid Ltd. (PYPD) Q3 2025 Earnings Call Transcript
Confident tone DPLEX 100 regulatory progress US market access study SHIELD II Phase III data and clinical profile
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
PolyPid Ltd. (PYPD) Q2 2025 Earnings Call Transcript
Confident tone SHIELD II Phase III Results Commercial Partnership Strategy Regulatory Pathway and NDA
Diluted EPS
$0.78
▼ 37.6% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript
Confident tone SHIELD 2 Phase 3 Trial Regulatory Submissions D-PLEX100 Product
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript
Confident tone D-PLEX100 Product Candidate SHIELD II Phase 3 Trial Progress Regulatory Path and NDA
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript
Confident tone SHIELD II Trial Progress and Enrollment D-PLEX100 Product Profile and Publication Interim Analysis Outcome Scenarios
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
PolyPid Ltd. (PYPD) Q2 2024 Earnings Call Transcript
Positive tone SHIELD II trial enrollment and timeline SHIELD I learnings and de-risking Financing and cash runway
Diluted EPS
$1.25
▼ 68.4% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
PolyPid Ltd. (PYPD) Q1 2024 Earnings Call Transcript
Confident tone D-PLEX100 Regulatory and NDA Pathway SHIELD II Phase III Trial Enrollment Progress Patient Demographics and Trial Design Lessons
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
PolyPid Ltd. (PYPD) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
PolyPid Ltd. (PYPD) Q2 2023 Earnings Call Transcript
Diluted EPS
$3.95
▼ 78.4% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
PolyPid Ltd. (PYPD) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
PolyPid Ltd. (PYPD) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
PolyPid Ltd. (PYPD) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
PolyPid Ltd. (PYPD) Q2 2022 Earnings Call Transcript
Diluted EPS
$18.30
▲ 8.9% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
PolyPid Ltd. (PYPD) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
PolyPid Ltd. (PYPD) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
PolyPid Ltd. (PYPD) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
PolyPid Ltd. (PYPD) Q2 2021 Earnings Call Transcript
Diluted EPS
$16.80
▼ 97.8% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
PolyPid Ltd. (PYPD) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
PolyPid Ltd. (PYPD) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
PolyPid Ltd. (PYPD) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
PolyPid Ltd. (PYPD) Q2 2020 Earnings Call Transcript
Diluted EPS
$759.00
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1611842 CUSIP M8001Q126 13F (30d) 12 filings 12 filers Visit website Investor relations